| CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine L Kong, Y Zhang, ZQ Ye, XQ Liu, SQ Zhao, L Wei, G Gao Nucleic acids research 35 (suppl_2), W345-W349, 2007 | 2538 | 2007 |
| Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy R Cristescu, R Mogg, M Ayers, A Albright, E Murphy, J Yearley, X Sher, ... Science 362 (6411), eaar3593, 2018 | 1810 | 2018 |
| Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer ST Kim, R Cristescu, AJ Bass, KM Kim, JI Odegaard, K Kim, XQ Liu, ... Nature medicine 24 (9), 1449-1458, 2018 | 1243 | 2018 |
| Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing SS Wong, KM Kim, JC Ting, K Yu, J Fu, S Liu, R Cristescu, M Nebozhyn, ... Nature communications 5 (1), 5477, 2014 | 171 | 2014 |
| High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features X Liu, MG Choi, K Kim, KM Kim, ST Kim, SH Park, R Cristescu, S Peter, ... Pathology-Research and Practice 216 (4), 152881, 2020 | 93 | 2020 |
| Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors R Cristescu, D Aurora-Garg, A Albright, L Xu, XQ Liu, A Loboda, L Lang, ... Journal for immunotherapy of cancer 10 (1), 2022 | 90 | 2022 |
| Comprehensive characterization of oncogenic drivers in Asian lung adenocarcinoma S Li, YL Choi, Z Gong, X Liu, M Lira, Z Kan, E Oh, J Wang, JC Ting, X Ye, ... Journal of Thoracic Oncology 11 (12), 2129-2140, 2016 | 90 | 2016 |
| Finding new structural and sequence attributes to predict possible disease association of single amino acid polymorphism (SAP) ZQ Ye, SQ Zhao, G Gao, XQ Liu, RE Langlois, H Lu, L Wei Bioinformatics 23 (12), 1444-1450, 2007 | 70 | 2007 |
| WebLab: a data-centric, knowledge-sharing bioinformatic platform X Liu, J Wu, J Wang, X Liu, S Zhao, Z Li, L Kong, X Gu, J Luo, G Gao Nucleic acids research 37 (suppl_2), W33-W39, 2009 | 51 | 2009 |
| RNA-seq identified a super-long intergenic transcript functioning in adipogenesis F Yi, F Yang, X Liu, H Chen, T Ji, L Jiang, X Wang, Z Yang, LH Zhang, ... RNA biology 10 (6), 990-1001, 2013 | 43 | 2013 |
| Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial JY Hong, HJ Cho, JK Sa, X Liu, SY Ha, T Lee, H Kim, W Kang, DH Sinn, ... Genome medicine 14, 1-15, 2022 | 40 | 2022 |
| Genome-wide identification of RNA editing in hepatocellular carcinoma L Kang, X Liu, Z Gong, H Zheng, J Wang, Y Li, H Yang, J Hardwick, H Dai, ... Genomics 105 (2), 76-82, 2015 | 37 | 2015 |
| Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple … L Zhang, X Liu, X Zhang, R Chen Molecular Genetics and Genomics 291, 1035-1051, 2016 | 36 | 2016 |
| Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq L Zhang, S Li, YL Choi, J Lee, Z Gong, X Liu, Y Pei, A Jiang, M Ye, M Mao, ... Lung cancer 109, 21-27, 2017 | 30 | 2017 |
| Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor types A Chhibber, L Huang, H Zhang, J Xu, R Cristescu, X Liu, DV Mehrotra, ... Immunity 55 (1), 56-64. e4, 2022 | 22 | 2022 |
| Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study IM Shui, XQ Liu, Q Zhao, ST Kim, Y Sun, JH Yearley, T Choudhury, ... Journal for Immunotherapy of Cancer 10 (7), 2022 | 15 | 2022 |
| Large-scale evaluation of concordance of genomic scores in whole exome sequencing and Foundation Medicine comprehensive genomic platform across cancer types D Aurora-Garg, A Albright, P Qiu, Y Li, X Liu, D Fabrizio, L Lang, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | 15 | 2019 |
| Mutational load (ML) and T-cell-inflamed microenvironment as predictors of response to pembrolizumab. R Cristescu, R Mogg, M Ayers, A Albright, E Murphy, J Yearley, X Sher, ... Journal of Clinical Oncology 35 (7_suppl), 1-1, 2017 | 15 | 2017 |
| Immune biomarkers in metastatic castration-resistant prostate cancer MDF de la Maza, K Chandran, J Rekowski, IM Shui, B Gurel, E Cross, ... European Urology Oncology 5 (6), 659-667, 2022 | 11 | 2022 |
| Erratum: Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy (Science R Cristescu, R Mogg, M Ayers, A Albright, E Murphy, J Yearley, X Sher, ... Science 363 (6430), eaax1384, 2019 | 10 | 2019 |
